SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Fermenta Biotech - Quaterly Results

12 Nov 2021 Evaluate
A fair growth of 6.10% in the revenue at Rs. 990.10 millions was reported in the September 2021 quarter as compared to Rs. 933.19 millions during year-ago period.Profit after Tax for the quarter ended September 2021 saw a decline of -56.06% from Rs. 149.43 millions to Rs. 65.66  millions.A decline of 198.95 millions was observed in the OP in the quarter ended September 2021 from 285.83 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 990.10 933.19 6.10 2078.94 1942.48 7.03 3728.22 3005.07 24.06
Other Income 23.52 9.37 151.01 34.24 22.14 54.65 66.18 123.13 -46.25
PBIDT 198.95 285.83 -30.40 485.40 547.17 -11.29 1003.36 818.05 22.65
Interest 44.44 54.72 -18.79 86.24 90.93 -5.16 180.75 193.20 -6.44
PBDT 154.51 231.11 -33.14 399.16 456.24 -12.51 822.61 624.85 31.65
Depreciation 59.75 45.41 31.58 114.37 84.16 35.90 190.31 149.38 27.40
PBT 94.76 185.70 -48.97 284.79 372.08 -23.46 632.30 475.47 32.98
TAX 29.10 36.27 -19.77 91.27 59.57 53.21 112.60 -161.24 -169.83
Deferred Tax 12.57 3.32 278.61 41.54 -7.39 -662.11 0.03 -194.89 -100.02
PAT 65.66 149.43 -56.06 193.52 312.51 -38.08 519.70 636.71 -18.38
Equity 144.24 144.24 0.00 144.24 144.24 0.00 144.24 144.24 0.00
PBIDTM(%) 20.09 30.63 -34.40 23.35 28.17 -17.11 26.91 27.22 -1.14

Fermenta Biotech Share Price

312.55 -9.30 (-2.89%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×